Organisation paid for research Program year 2022 Source: CMS Open Payments

Moore Clinical Research Inc.

Neither a doctor nor a teaching hospital

Research payments

$435,154

49 payments

Through program year 2022, Moore Clinical Research Inc. is reported as receiving $435,154 in research payments, across 49 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2022	Research	$31,991	8
2021	Research	$403,163	41

Breakdown

Who paid Research payments · program years 2021–2022

Taro Pharmaceuticals USA, Inc. $318,232 47 payments
Amgen Inc. $116,922 2 payments

Studies the money was for Research payments · program years 2021–2022

Study $147,137 26 payments
ABP 654 P3 PsO Study $116,922 2 payments
A Study Comparing Tretinoin Gel Microsphere, 0.1 and RETIN-A MICRO Gel Microsphere, 0.1 in the Treatment of Acne Vulgaris $108,239 3 payments
THRC 2026 $29,586 5 payments
A Study Comparing ADAPALENE 0.1% and to Differin Gel in the Treatment of Acne Vulgaris $19,749 1 payment
A Phase II, Randomized, Double Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of AS012 in Subjects With Non-segmental Vitiligo $11,116 9 payments
HLBT 2001 $2,405 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.